Pharmaceutical giant Synaptogenix makes first purchase of TAO to lay out AI and machine learning strategies

【coin界】Biopharmaceutical company Synaptogenix (NASDAQ: SNPX) announced its first purchase of TAO, with the specific purchase amount undisclosed. This is part of the company’s recent announcement of a financial strategy focused on artificial intelligence (AI) and machine learning Cryptocurrency, which will choose a certain platform to provide qualified accomplice management, stake, and trading services for Synaptogenix’s TAO assets.

TAO0,49%
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • 10
  • Repost
  • Share
Comment
0/400
No comments
  • Pin

Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)